Nemaura Medical Accounts Payable

Nemaura Medical posts a accounts payable of $350K as of December 2023. That compares with $170K in the prior-year period — up 105.9% year over year. Comparing that reading with peers and prior periods is usually more useful than looking at the number in isolation.

In the prior comparable period, Nemaura Medical's accounts payable was $170K. The latest reading is $350K — a 105.9% year-over-year increase (period ending December 2023). Use the history and growth charts on this page for a longer lookback.

Accounts Payable is one piece of Nemaura Medical's financial statement story. At $350K, it should be interpreted next to related metrics — for example revenue with costs, assets with liabilities, or income with margins. Stockcircle links those related pages so you can move from this number to the surrounding context quickly.

Context for NMRD's accounts payable usually means three checks: (1) trend versus prior periods, (2) level versus peers, and (3) consistency with growth and profitability. This page covers the first two; Nemaura Medical's other metric pages and overview cover the third.

Judging Nemaura Medical against Healthcare peers is usually better than using a market-wide rule of thumb. Business models inside Healthcare are more comparable, which makes gaps in accounts payable easier to interpret. Start with $350K here, then scan peer and history charts to see if the gap is persistent.